| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―May―24 |
The association of polypharmacy with COVID-19 outcomes independent of comorbidities in people with type 2 diabetes: implications for the unforeseen consequences of polypharmacy |
Juhi K. Gupta, Rathi Ravindrarajah, George Tilston, Wiliam Ollier, Darren M. Ashcroft, Adrian H. Heald |
| 2 |
[GO] |
2022―Sep―06 |
National level prescribing of psychotropic medication in primary care during the COVID-19 pandemic in England: potential implications for cardiometabolic health |
Unaiza Waheed, Mike Stedman, Mark Davies, Andreas Walther, Emma Solomon, Bill Ollier, Adrian H. Heald |
| 3 |
[GO] |
2022―Apr―13 |
Reducing fatigue-related symptoms in Long COVID-19: a preliminary report of a lymphatic drainage intervention |
Adrian H. Heald, Raymond Perrin, Andreas Walther, Mike Stedman, Mark Hann, Annice Mukherjee, Lisa Riste |
| 4 |
[GO] |
2022―Jan―31 |
Application of a city wide digital population database for outcome analysis in diabetes: SARS-CoV-2, diabetes and hospital admission rate month by month in Greater Manchester, UK |
Adrian H. Heald, David A. Jenkins, Nadia Chaudhury, Richard Williams, Matthew Sperrin, Niels Peek, et al. (+5) William Ollier, Kelly Bowden-Davies, Gayathri Delanerolle, Simon G. Anderson, John Martin Gibson |
| 5 |
[GO] |
2022―Jan―31 |
SARS-CoV-2, diabetes and mortality: month by month variation in mortality rate from June 2020 to June 2021 |
Adrian H. Heald, David A. Jenkins, Nadia Chaudhury, Richard Williams, Matthew Sperrin, Niels Peek, et al. (+5) William Ollier, Kelly Bowden-Davies, Gayathri Delanerolle, Simon G. Anderson, John Martin Gibson |
| 6 |
[GO] |
2021―Oct―29 |
The risk factors potentially influencing risk of serious illness/death in people with diabetes, following SARS-CoV-2 infection |
Adrian Heald, Mark Livingston, Gabriela Moreno, John Martin Gibson |
| 7 |
[GO] |
2021―Aug―21 |
The microvascular hypothesis underlying neurologic manifestations of long COVID-19 and possible therapeutic strategies |
|
| 8 |
[GO] |
2021―Jan―20 |
Salivary markers and coronavirus disease 2019 |
Antoine AbdelMassih, Alaa A. Hassan, Aya S. Abou-Zeid, Aya Hassan, Engy Hussein, Mahenar Gadalla, et al. (+14) Mahinour Hussein, Maryam A. Eid, Maryam Elahmady, Nadine El Nahhas, Nadine Emad, Nihal Zahra, Nour Aboushadi, Nourhan Ibrahim, Sherouk Mokhtar, Habiba-Allah Ismail, Nadine El-Husseiny, Reham Khaled Moharam, Esraa Menshawey, Rahma Menshawey |
| 9 |
[GO] |
2020―Sep―20 |
COVID-19 pandemic |
Ertan Yetkin, Gökay Taylan, Kenan Yalta |
| 10 |
[GO] |
2020―Jun―15 |
Obese communities among the best predictors of COVID-19-related deaths |
Antoine AbdelMassih, Ramy Ghaly, Abeer Amin, Amr Gaballah, Aya Kamel, Bassant Heikal, et al. (+20) Esraa Menshawey, Habiba-Allah Ismail, Hend Hesham, Josephine Attallah, Kirollos Eshak, Mai Moursi, Mariam Khaled-Ibn-ElWalid, Marwa Tawfik, Mario Tarek, Mayan Mohy-El-Din, Menna Habib, Nada Hafez, Odette Bahnan, Passant Ismail, Sara Senoussy, Sherry Ghaly, Sousanna Farah, Rafeef Hozaien, Veronia Adel, Mariam Khaled |
| 11 |
[GO] |
2020―Jun―01 |
Is it infection or rather vascular inflammation? Game-changer insights and recommendations from patterns of multi-organ involvement and affected subgroups in COVID-19 |
Antoine Fakhry AbdelMassih, Aya Kamel, Fady Mishriky, Habiba-Allah Ismail, Layla El Qadi, Lauris Malak, et al. (+14) Miral El-Husseiny, Mirette Ashraf, Nada Hafez, Nada AlShehry, Nadine El-Husseiny, Nora AbdelRaouf, Noura Shebl, Nouran Hafez, Nourhan Youssef, Peter Afdal, Rafeef Hozaien, Rahma Menshawey, Rana Saeed, Raghda Fouda |
| 12 |
[GO] |
2020―May―08 |
Possible molecular and paracrine involvement underlying the pathogenesis of COVID-19 cardiovascular complications |
Antoine Fakhry AbdelMassih, David Ramzy, Lauren Nathan, Silvia Aziz, Mirette Ashraf, Nourhan Hatem Youssef, et al. (+3) Nouran Hafez, Rana Saeed, Hala Agha |
|
